Felzartamab, an investigational antibody, reduces triggers linked to IgA nephropathy, an autoimmune kidney disease, suggesting lasting clinical...
Vous n'êtes pas connecté
ccf-DNA activates the cGAS/STING pathway, driving inflammation in anti-NXP2 antibody-positive dermatomyositis patients.
Felzartamab, an investigational antibody, reduces triggers linked to IgA nephropathy, an autoimmune kidney disease, suggesting lasting clinical...
Researchers examine how sleep impacts inflammation and recovery following a heart attack.
Understanding in depth how tumours evolve to become malignant is the objective of the latest study led by the Cell Plasticity in Development and...
Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight patients with chronic...
In patients with medlinkchronic kidney disease/medlink, irreversible disease progression is triggered by the loss of podocytes, essential components...
MILAN, Nov. 1, 2024. Diadem SpA, in partnership with researchers from the University of Texas Medical Branch, led by Prof. Rakez Kayed from the...
The detailed study results confirmed interim findings, showing stable kidney function and sustained treatment effect more than 18 months after the...
Scientists at the Gladstone Institutes have discovered how immune cells in the heart trigger scarring, a process known as fibrosis, which plays a key...
RICHMOND, Calif.--(BUSINESS WIRE)--Oct. 22, 2024-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the outcome...